136 related articles for article (PubMed ID: 8798441)
1. CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas.
Ji L; Mochon E; Arcinas M; Boxer LM
J Biol Chem; 1996 Sep; 271(37):22687-91. PubMed ID: 8798441
[TBL] [Abstract][Full Text] [Related]
2. The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas.
Heckman C; Mochon E; Arcinas M; Boxer LM
J Biol Chem; 1997 Aug; 272(31):19609-14. PubMed ID: 9235968
[TBL] [Abstract][Full Text] [Related]
3. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
4. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis.
Wilson BE; Mochon E; Boxer LM
Mol Cell Biol; 1996 Oct; 16(10):5546-56. PubMed ID: 8816467
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.
Arcinas M; Heckman CA; Mehew JW; Boxer LM
Cancer Res; 2001 Jul; 61(13):5202-6. PubMed ID: 11431360
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
Heckman CA; Mehew JW; Boxer LM
Oncogene; 2002 May; 21(24):3898-908. PubMed ID: 12032828
[TBL] [Abstract][Full Text] [Related]
7. Differential binding of cAMP-responsive-element (CRE)-binding protein-1 and activating transcription factor-2 to a CRE-like element in the human tissue-type plasminogen activator (t-PA) gene promoter correlates with opposite regulation of t-PA by phorbol ester in HT-1080 and HeLa cells.
Costa M; Medcalf RL
Eur J Biochem; 1996 May; 237(3):532-8. PubMed ID: 8647095
[TBL] [Abstract][Full Text] [Related]
8. NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.
Ji L; Arcinas M; Boxer LM
Mol Cell Biol; 1994 Dec; 14(12):7967-74. PubMed ID: 7969136
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
Heckman CA; Wheeler MA; Boxer LM
Oncogene; 2003 Sep; 22(39):7891-9. PubMed ID: 12970736
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene.
Majumder S; Varadharaj S; Ghoshal K; Monani U; Burghes AH; Jacob ST
J Biol Chem; 2004 Apr; 279(15):14803-11. PubMed ID: 14742439
[TBL] [Abstract][Full Text] [Related]
11. A submicroscopic interstitial deletion of chromosome 14 frequently occurs adjacent to the t(14;18) translocation breakpoint in human follicular lymphoma.
Zelenetz AD; Cleary ML; Levy R
Genes Chromosomes Cancer; 1993 Mar; 6(3):140-50. PubMed ID: 7682098
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor, Nm23H2, binds to and activates the translocated c-myc allele in Burkitt's lymphoma.
Ji L; Arcinas M; Boxer LM
J Biol Chem; 1995 Jun; 270(22):13392-8. PubMed ID: 7768941
[TBL] [Abstract][Full Text] [Related]
13. Evidence that an additional conserved element with the consensus C/GAGA/C is essential for maximal responsiveness of the cyclic AMP enhancer.
Kwast-Welfeld J; Walker PR; Whitfield JF; Sikorska M
Cell Mol Biol Res; 1993; 39(3):231-42. PubMed ID: 7904879
[TBL] [Abstract][Full Text] [Related]
14. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
15. Analysis of molecular mechanisms controlling neuroendocrine cell specific transcription of the chromogranin A gene.
Canaff L; Bevan S; Wheeler DG; Mouland AJ; Rehfuss RP; White JH; Hendy GN
Endocrinology; 1998 Mar; 139(3):1184-96. PubMed ID: 9492053
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE.
Pearman AT; Chou WY; Bergman KD; Pulumati MR; Partridge NC
J Biol Chem; 1996 Oct; 271(41):25715-21. PubMed ID: 8810350
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of a dominant negative CREB protein in HT-1080 cells selectively disrupts plasminogen activator inhibitor type 2 but not tissue-type plasminogen activator gene expression.
Costa M; Shen Y; Medcalf RL
FEBS Lett; 2000 Sep; 482(1-2):75-80. PubMed ID: 11018526
[TBL] [Abstract][Full Text] [Related]
18. A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP.
Medcalf RL; Rüegg M; Schleuning WD
J Biol Chem; 1990 Aug; 265(24):14618-26. PubMed ID: 2167321
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of the human renin promoter by the cyclic AMP/protein kinase A pathway is mediated by both cAMP-responsive element binding protein-1 (CREB)-dependent and CREB-independent mechanisms in Calu-6 cells.
Ying L; Morris BJ; Sigmund CD
J Biol Chem; 1997 Jan; 272(4):2412-20. PubMed ID: 8999953
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
